+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Genotyping Market Research and Forecast, 2019-2025

  • ID: 4757154
  • Report
  • Region: Global
  • Orion Market Research Private Limited
UP TO OFF
until Aug 31st 2019
1 of 3

FEATURED COMPANIES

  • CRISPR Therapeutics AG
  • Deep Genomics
  • Fluidigm Corp.
  • GENEWIZ
  • Merck KGaA
  • PerkinElmer, Inc.
  • MORE
Global Genotyping Market, Size, Share & Trends Analysis Report, by Products (Kits & Reagents and Instruments), by Technology (Mass Spectrometry, Microarray, Sequencing, PCR, Electrophoresis, and Others) by Application (Drug Discovery, Personalized Medicine, Pharma Genomics, and Diagnostic Research) and Forecast, 2019-2025.

Genotyping is a technique of defining genetic make-up differences of an individual by examining the individual’s DNA sequence by means of the biological assays and for comparing it to another individual’s sequence. Genotyping allows researchers to explore genetic variants such as single nucleotide polymorphisms (SNPs) and large structural changes in DNA. Genotypic offers a wide range of comprehensive bioinformatics services and enable researchers to interpret data efficiently. The genomic solution is defined as complete expertise in bioinformatics, microarray, and sequencing technologies. Genotyping is considered as the technique to define genetic make-up differences and enables to evaluate the factors contributing to the growth of the market include increasing demand for genome analysis, increasing adoption of genotyping in drug discovery and personalized medicines. The precision medicine Initiative is a research endeavor, which involved National Institutes of Health (NIH) and various other research centers, which focuses to determine approaches to treat or prevent diseases. The Initiative focuses both short-term and long-term goals, the short-term goals involves to expands precision medicine for cancer research. Whereas the long-term goals focus to bring precision medicine to all areas of health and healthcare on a large scale. The high-throughput next-generation sequencing (NGS) technologies are evolved rapidly in drug development and genomics research. The significant advances in NGS technologies and the expansion of biological data and technical improvisation has reduced sequencing costs. The high cost of equipment used in genotyping is the major restraint for the market. There are various data analysis issues during microarray experiments, as it may provide bias results developed through experiments which is also considered as a limiting factor in the growth of the market.

The genotyping market is segmented on the basis of product, technology, and application. On the basis of technology, the market is segmented into mass spectrometry, microarray, sequencing, polymerase chain reaction (PCR), electrophoresis, and others. The capillary electrophoresis (CE) is increasing its influence in the pharmaceutical field such as in biomedical analysis. The technique is used to optimize the determination of small molecules and used in biomarker discovery, with some detection techniques such as laser-induced fluorescence (CE-LIF), electrochemical detection (CE-ECD) and mass spectrometry (CE-MS). The technology provides high chromatographic resolution, a small volume of sample is needed and gives quick analysis. The diagnosis of diseases such as multiple myeloma, hemoglobinopathies, and diabetes are major diseases. The CE technology enables to monitors and diagnoses diseases, as the technology enables to separate, quantitate complex molecules of Hb variants, protein, and immunoglobulins. The capillary electrophoresis is an advanced technology, which is used globally.

Geographically, the market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America region is dominating the global genotyping market. The adoption of advanced technology and increasing healthcare infrastructure in the region is contributing in the market growth within the North American region. However, in Asia-Pacific, the awareness about genotyping is increasing, as genotyping tests enables to control genetic diseases. Asia-Pacific is considered as the growing market during the forecast period. There are various companies involved in the genotyping technology such as Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., CRISPR Therapeutics, Deep Genomics, Eurofins Scientific, Fluidigm Corporation, IBM Corporation, Illumina, Inc. and so on. The companies are focused on developing advanced genotyping to stay competitive in the market. Geographical expansion, merger & acquisition, finding a new market or innovate in their core competency in order to expand individual market share is a key strategy adopted by major market players.

Research Methodology

The market study of the global genotyping market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Authentic Public Databases such as the Organisation for Economic Co-operation and Development (OECD), World Health Organization (WHO), and others
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog.
The report is intended for research organizations, biotechnology companies, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Genotyping Market Research and Analysis by Product
2. Global Genotyping Market Research and Analysis by Technology
3. Global Genotyping Market Research and Analysis by Application

The Report Covers:
  • Comprehensive research methodology of the global genotyping market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global genotyping market.
  • Insights about market determinants which are stimulating the global genotyping market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • CRISPR Therapeutics AG
  • Deep Genomics
  • Fluidigm Corp.
  • GENEWIZ
  • Merck KGaA
  • PerkinElmer, Inc.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Thermo Fisher Scientific, Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. PerkinElmer, Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Agilent Technologies, Inc.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Merck KGaA
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. GE Healthcare
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Genotyping Market by Products
5.1.1. Reagents & Kits
5.1.2. Instruments
5.2. Global Genotyping Market by Technology
5.2.1. Mass Spectrometry
5.2.2. Microarray
5.2.3. Sequencing
5.2.4. Polymerase Chain Reaction
5.2.5. Electrophoresis
5.2.6. Others
5.3. Global Genotyping Market by Application
5.3.1. Drug Discovery
5.3.2. Personalized Medicine
5.3.3. Diagnostic Research
5.3.4. Pharma Genomics
5.3.5. Others

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. Japan
6.3.3. India
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Agilent Technologies, Inc.
7.2. Bio-Rad Laboratories, Inc.
7.3. CRISPR Therapeutics AG
7.4. Danaher Corporation
7.5. Deep Genomics
7.6. Eurofins GSC Lux SARL
7.7. Fluidigm Corp.
7.8. General Electric Co.
7.9. GENEWIZ
7.10. Illumina, Inc.
7.11. Integrated DNA Technologies, Inc.
7.12. Intellia Therapeutics Inc.
7.13. Merck KGaA
7.14. Pacific Biosciences of California, Inc.
7.15. Pathway Genomics Corp.
7.16. PerkinElmer, Inc.
7.17. QIAGEN N.V.
7.18. Quantabio
7.19. Roche Molecular Systems, Inc.
7.20. Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • CRISPR Therapeutics AG
  • Danaher Corporation
  • Deep Genomics
  • Eurofins GSC Lux SARL
  • Fluidigm Corp.
  • General Electric Co.
  • GENEWIZ
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Intellia Therapeutics Inc.
  • Merck KGaA
  • Pacific Biosciences of California, Inc.
  • Pathway Genomics Corp.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Quantabio
  • Roche Molecular Systems, Inc.
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4757154
Adroll
adroll